Pharmaceuticals News

Oncolytics Biotech announced updates on the GOBLET Phase 1/2 study and that it will receive final payment under the PanCAN grant this quarter.

Three-year real-world study compares treatment outcomes in adults with XLH, including serum phosphate, pain, stiffness, and physical function.

Dongsung Chemical and CJ Biomaterials Introduce First PHA-Based ECOVIVA® Hotmelt Adhesive Available in the US Market

CAMBRIDGE, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today...

Company brings its expertise in driving faster site activation and enrollment and better patient retention to panel discussions; continues commitment to helping sites navigate growing trial...

Collaboration combines INmune Bio's clinical research with QCi's  Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XProInitial engagement marks...

"The data published in Scientific Reports provide clear evidence that our synergistic PRP formulation can inhibit key drivers of tumor progression"

CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset

MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are...

PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies...